HCA (HCA) Stock Rating Upgraded by ValuEngine
HCA (NYSE:HCA) was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating in a research report issued on Thursday.
HCA has been the subject of several other reports. Robert W. Baird reissued a “buy” rating on shares of HCA in a research report on Thursday, September 28th. Credit Suisse Group started coverage on shares of HCA in a research report on Thursday, November 2nd. They issued an “outperform” rating and a $95.00 price objective for the company. Cantor Fitzgerald reissued a “buy” rating and issued a $95.00 price objective on shares of HCA in a research report on Friday, October 13th. Piper Jaffray Companies reissued a “buy” rating and issued a $92.00 price objective on shares of HCA in a research report on Wednesday, October 4th. Finally, Raymond James Financial cut shares of HCA from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, October 18th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and eighteen have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $90.20.
Shares of HCA (NYSE HCA) traded up $4.86 during trading hours on Thursday, reaching $85.00. 8,262,246 shares of the company traded hands, compared to its average volume of 2,283,438. The company has a market cap of $27,640.88, a P/E ratio of 11.85, a price-to-earnings-growth ratio of 1.15 and a beta of 0.50. HCA has a one year low of $69.59 and a one year high of $91.03. The company has a debt-to-equity ratio of -6.46, a current ratio of 1.68 and a quick ratio of 1.41.
In other news, insider Michael S. Cuffe sold 2,150 shares of the company’s stock in a transaction that occurred on Tuesday, October 17th. The shares were sold at an average price of $78.00, for a total value of $167,700.00. Following the completion of the sale, the insider now owns 12,476 shares of the company’s stock, valued at approximately $973,128. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Victor L. Campbell sold 8,000 shares of the company’s stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $75.82, for a total transaction of $606,560.00. Following the completion of the sale, the senior vice president now directly owns 127,275 shares of the company’s stock, valued at approximately $9,649,990.50. The disclosure for this sale can be found here. Insiders sold a total of 22,450 shares of company stock valued at $1,737,681 in the last ninety days. Corporate insiders own 2.90% of the company’s stock.
Several institutional investors and hedge funds have recently made changes to their positions in HCA. Longview Partners Guernsey LTD lifted its position in shares of HCA by 22.6% in the 3rd quarter. Longview Partners Guernsey LTD now owns 11,135,155 shares of the company’s stock worth $886,247,000 after purchasing an additional 2,053,701 shares during the period. APG Asset Management N.V. lifted its position in shares of HCA by 141.4% in the 3rd quarter. APG Asset Management N.V. now owns 3,423,381 shares of the company’s stock worth $272,467,000 after purchasing an additional 2,005,193 shares during the period. Assenagon Asset Management S.A. lifted its position in shares of HCA by 1,500.3% in the 3rd quarter. Assenagon Asset Management S.A. now owns 1,579,382 shares of the company’s stock worth $125,703,000 after purchasing an additional 1,480,690 shares during the period. American Century Companies Inc. lifted its position in shares of HCA by 49.5% in the 3rd quarter. American Century Companies Inc. now owns 2,558,216 shares of the company’s stock worth $203,608,000 after purchasing an additional 847,377 shares during the period. Finally, Northwestern Mutual Investment Management Company LLC lifted its position in shares of HCA by 1,229.5% in the 2nd quarter. Northwestern Mutual Investment Management Company LLC now owns 775,914 shares of the company’s stock worth $59,753,000 after purchasing an additional 717,551 shares during the period. 75.35% of the stock is owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: “HCA (HCA) Stock Rating Upgraded by ValuEngine” was first posted by American Banking News and is the property of of American Banking News. If you are reading this article on another website, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.americanbankingnews.com/2017/11/30/hca-hca-stock-rating-upgraded-by-valuengine.html.
HCA Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.